US20130273645A1 - Detection instrument, and detection system - Google Patents

Detection instrument, and detection system Download PDF

Info

Publication number
US20130273645A1
US20130273645A1 US13/995,576 US201113995576A US2013273645A1 US 20130273645 A1 US20130273645 A1 US 20130273645A1 US 201113995576 A US201113995576 A US 201113995576A US 2013273645 A1 US2013273645 A1 US 2013273645A1
Authority
US
United States
Prior art keywords
detection
nucleic acid
acid portion
enzyme
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/995,576
Other languages
English (en)
Inventor
Iwao Waga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEC Solution Innovators Ltd
Original Assignee
NEC Solution Innovators Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEC Solution Innovators Ltd filed Critical NEC Solution Innovators Ltd
Assigned to NEC CORPORATION reassignment NEC CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WAGA, IWAO
Assigned to NEC SOFT, LTD. reassignment NEC SOFT, LTD. CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 030653 FRAME 0786. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE AS: NEC SOFT, LTD., 18-7, SHINKIBA 1-CHOME, KOTO-KU, TOKYO, JAPAN. Assignors: WAGA, IWAO
Publication of US20130273645A1 publication Critical patent/US20130273645A1/en
Assigned to NEC SOLUTION INNOVATORS, LTD. reassignment NEC SOLUTION INNOVATORS, LTD. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: NEC SOFT, LTD.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5302—Apparatus specially adapted for immunological test procedures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/54—Labware with identification means
    • B01L3/545—Labware with identification means for laboratory containers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6823—Release of bound markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/02—Identification, exchange or storage of information
    • B01L2300/021—Identification, e.g. bar codes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0627—Sensor or part of a sensor is integrated

Definitions

  • the present invention relates to a detection instrument and a detection system.
  • Sanitation inspections and contamination inspections are carried out in the food production stage because of the requirement by the food sanitation law and the voluntary management by food companies and the like.
  • skilled techniques are required in order to carry out these inspections of food quality. Therefore, it is rare that food quality is inspected in a distribution stage and a consumption stage. That is, it is impossible to inspect food quality by part-time workers having no skilled technique in supermarkets, department stores, convenience stores, and restaurants in the same manner as in food factories.
  • the present invention is intended to provide a detection instrument and a detection system, capable of easily detecting an intended detection object without any skilled technique.
  • the detection instrument is a detection instrument including: a detection portion, wherein a detection reagent which develops a color by specifically reacting with a detection object in a sample is placed in the detection portion, positional information of the detection reagent in the detection portion is information on the detection object, and color development of the detection reagent can be optically read.
  • the detection system according to the present invention is a detection system including: the detection instrument according to the present invention; and an optical reader, wherein the detection object is detected by reading color development of the detection reagent in the detection instrument by the optical reader.
  • the present invention uses an easy method of optically reading color development of a detection reagent. Thus, according to the present invention, everyone can easily detect an intended detection object without any skilled technique.
  • FIG. 1A is a plan view showing an example of a configuration of a detection instrument of Embodiment 1 according to the present invention.
  • FIG. 1B is a plan view showing another example of a configuration of a detection instrument of Embodiment 1 according to the present invention.
  • FIGS. 2A and 2B are plan views illustrating an example of detection of a detection object in a detection portion of the detection instrument of Embodiment 1.
  • FIGS. 3A to 3D are plan views showing another example of detection of a detection object in a detection portion of the detection instrument of Embodiment 1.
  • FIGS. 4A to 4D are plan views showing yet another example of detection of a detection object in a detection portion of the detection instrument of Embodiment 1.
  • FIGS. 5A and 5B are diagrams schematically showing a detection method for detecting a detection object using a detection instrument of Embodiment 1-1a according to the present invention.
  • FIGS. 6A and 6B show a specific example of the detection method in Embodiment 1-1a.
  • FIGS. 7A and 7B are diagrams schematically showing a detection method for detecting a detection object using a detection instrument of Embodiment 1-1b according to the present invention.
  • FIGS. 8A to 8D show a specific example of the detection method in Embodiment 1-1b.
  • FIG. 9 is a schematic view illustrating antibodies immobilized on a detection portion in a detection instrument of Embodiment 1-2 according to the present invention.
  • FIG. 10 is a schematic view illustrating the state of an antigen-antibody reaction in the detection instrument of Embodiment 1-2.
  • FIG. 11 is a schematic view showing an example of a configuration of a detection system of Embodiment 2 according to the present invention.
  • FIG. 12 is a schematic view showing an example of a configuration of a detection system of Embodiment 3 according to the present invention.
  • FIGS. 13A to 13C are views showing the respective detection instruments of Embodiments 4 to 6 according to the present invention.
  • the concept of “color development” encompasses coloring.
  • the concept of “detection” encompasses quantitative analysis, semi-quantitative analysis, and qualitative analysis.
  • FIG. 1A shows an example of a configuration of a detection instrument according to the present invention.
  • this detection instrument 1 is configured so that a detection portion 12 is formed in a main body 11 .
  • a detection reagent which develops a color by specifically reacting with a detection object in a sample is placed in the detection portion 12 .
  • positional information of the detection reagent is information on the detection object.
  • a bar code is formed in the detection portion 12 of the detection instrument according to the present invention as shown in FIG. 1A , and the detection reagent is placed as a part of the bar code.
  • the detection portion (bar code) 12 may include, besides information on the detection object, information such as information on the detection reagent (information on the kind of the detection reagent and the like) other than the positional information and information on a site at which detection is performed using the detection information, for example. With this embodiment, it is possible to detect the detection object with reference to information on the kind of the detection reagent, information on the site at which detection is performed, and the like.
  • the bar code is not limited to a one-dimensional code shown in FIG. 1A and may be, for example, a two-dimensional code such as a QR code (registered trademark) shown in FIG. 1B .
  • the detection instrument shown in FIG. 1A can be produced by forming a detection portion (bar code) 12 in a main body 11 of a detection instrument 1 .
  • a method for forming the detection portion (bar code) 12 is not particularly limited and can be, for example, a method such as printing using a printer such as an ink-jet recording device or a laser printer. In this case, for example, by causing the detection reagent to be contained in an ink or a toner at the time of printing a part of the detection portion (bar code) 12 , the detection reagent is placed as the part of the detection portion (bar code) 12 .
  • the detection reagent is not particularly limited as long as it develops a color by specifically reacting with a detection object in a sample, and examples thereof include a nucleic acid element described below, an antibody, and an antigen.
  • the method for using the detection instrument shown in FIG. 1A is, for example, as follows. Note here that the following method is a mere example, and the present invention is not limited by this.
  • the detection portion (bar code) 12 is brought into contact with a sample.
  • the detection reagent specifically reacts with the detection object and thus develops a color.
  • the sample is not particularly limited, and examples thereof include food (including beverages), pharmaceuticals, chemicals, the ground, animals, plants, microorganisms, virus, water (e.g., tap water, discharged water, river water, seawater, rainwater, and snow), garbage, and waste.
  • the detection object is not particularly limited, and examples thereof include high-molecular compounds, low-molecular compounds, organic substances, and inorganic substances.
  • the high-molecular compounds or the organic substances include microorganisms, virus, polysaccharides, proteins, nucleic acids, and resins.
  • the low-molecule compounds include pesticides, pharmaceuticals, chemicals, oligosaccharides, monosaccharides, lipids, oligopeptides, amino acids, vitamins, and bioactive substances.
  • the inorganic substances include minerals, mineral acids, and metals.
  • FIGS. 2A and 2B An example of detecting the detection object in the detection portion is described with reference to FIGS. 2A and 2B .
  • the identical parts to those in FIGS. 1A and 1B are denoted by identical reference numerals.
  • a bar code is formed in the detection portion 12 , and a detection reagent 1 a is placed as a part of the bar code.
  • positional information of the detection reagent 1 a is information on the detection object.
  • the detection reagent 1 a is placed adjacent to a bar 1 b in the detection portion (bar code) 12 .
  • the detection reagent 1 a placed adjacent to the bar 1 b specifically reacts with the detection object and develops a color as shown in FIG. 2B .
  • the detection object is an Escherichia coli O157 strain
  • a detection reagent which develops a color by contact with an Escherichia coli O157 strain is used as the detection reagent 1 a .
  • the thickness of the bar 1 b is increased by color development of the detection reagent 1 a as shown in FIG. 2B .
  • the bar 1 b is thin as it is (in the state shown in FIG. 2A ). Whether or not the thickness of the bar 1 b is increased is read by a bar-code reader and detected.
  • FIGS. 3A to 3D Another example of detection of the detection object in the detection portion is described with reference to FIGS. 3A to 3D .
  • the identical parts to those in FIGS. 1A to 2B are denoted by identical reference numerals.
  • a bar code is formed in the detection portion 12 , and three detection reagents 1 a , 2 a , and 3 a are placed as parts of the bar code.
  • a detection reagent for an Escherichia coli O157 strain as the detection reagent 1 a
  • a detection reagent for Salmonella enterica as the detection reagent 2 a
  • a detection reagent for Staphylococcus as the detection reagent 3 a are placed.
  • three pieces of positional information of the detection reagents 1 a , 2 a , and 3 a are the respective pieces of information on the three detection objects ( Escherichia coli O157 strain, Salmonella enterica , and Staphylococcus ).
  • the detection reagents 1 a , 2 a , and 3 a are placed adjacent to the respective bars 1 b , 2 b , and 3 b in the detection portion (bar code) 12 .
  • the three detection reagents 1 a , 2 a , and 3 a specifically react with the respective three detection objects ( Escherichia coli O157 strain, Salmonella enterica , and Staphylococcus ) and develop a color as shown in FIG. 3B .
  • two detection reagents 1 a and 2 a specifically react with the respective two detection objects ( Escherichia coli O157 strain and Salmonella enterica ) and develop a color as shown in FIG. 3C .
  • the detection reagent 1 a specifically reacts with the detection object ( Escherichia coli O157 strain) and develops a color as shown in FIG. 3D .
  • the thickness of a corresponding bar among the bars 1 b , 2 b , and 3 b is increased as shown in FIGS. 3B to 3D .
  • the bars 1 b , 2 b , and 3 b are thin as they are (in the state shown in FIG. 3A ).
  • the number of detection reagents is set to three, and the number of detection reagents, however, can be increased or decreased if necessary. With this configuration, a plurality of detection objects can be detected simultaneously.
  • the detection reagent may be placed on a part of or the entire bar code, and the part of or the entire bar code may be indistinguishable by color development of the detection reagent.
  • the present embodiment is described with reference to FIGS. 4A to 4D .
  • the identical parts to those in FIGS. 1A to 3D are denoted by identical reference numerals.
  • a bar code is formed in a detection portion 12 , and besides the bar code, eleven detection reagents 1 a are placed on the respective parts of the barcode.
  • positional information of the eleven detection reagents 1 a is information on the detection object.
  • the detection reagents 1 a specifically react with the detection object and develop a color as shown in FIG. 4B .
  • the detection object is an Escherichia coli O157 strain
  • a detection reagent which develops a color by contact with an Escherichia coli O157 strain is used as the detection reagents 1 a . It is checked and detected that a part of the bar code is indistinguishable by color development of the detection reagent 1 a using a bar-code reader.
  • a bar code is formed in the detection portion 12 , and besides the bar code, a detection reagent 1 a is placed on the entire bar code.
  • positional information of the detection reagent 1 a is information on the detection object.
  • the detection reagent 1 a specifically reacts with the detection object and develops a color as shown in FIG. 4D .
  • the detection reagent 1 a is used as the detection reagent 1 a . It is checked and detected that the entire bar code is indistinguishable by color development of the detection reagent 1 a using a bar-code reader.
  • the present embodiment is an example of a detection instrument in the case where the detection reagent contains a nucleic acid element.
  • the detection instrument of the present embodiment is a detection instrument wherein the detection reagent contains a nucleic acid element, the nucleic acid element contains a first nucleic acid portion and a second nucleic acid portion, the first nucleic acid portion is a binding portion which can bind to the detection object, the second nucleic acid portion is a labeling portion which can distinguish between binding and non-binding of the first nucleic acid portion and the detection object, and the labeling portion can cause the detection reagent to or not to develop a color according to the distinguishing between the binding and non-binding.
  • the kind of the nucleic acid is not particularly limited, and examples thereof include a single strand such as a single-stranded RNA or a single-stranded DNA and a double-stranded nucleic acid such as a double-stranded RNA or a double-stranded DNA.
  • the nucleic acids may be used alone or in a combination of two or more of them.
  • the nucleic acid may have a secondary structure formed by self-annealing, for example.
  • the secondary structure can be, for example, a stem-loop structure.
  • the nucleic acid may have, for example, a naturally-derived nucleic acid sequence or a synthesized nucleic acid sequence.
  • a method for synthesizing the nucleic acid is not at all limited and can be, for example, a method in which a nucleic acid is chemically synthesized from terminal bases using dNTP or the like as a material by a DNA synthesizer or an RNA synthesizer. Examples of the nucleic acid include DNA and RNA as mentioned above.
  • the nucleic acid may contain peptide nucleic acid such as PNA, for example.
  • the nucleic acid may contain a natural nucleic acid (nonartificial nucleic acid) such as A, C, G, T, or U or may contain an artificial nucleic acid such as 2′-fluorouracil, 2′-aminouracil, 2′-O-methyluracil, or 2-thiouracil, for example.
  • a natural nucleic acid nonartificial nucleic acid
  • an artificial nucleic acid such as 2′-fluorouracil, 2′-aminouracil, 2′-O-methyluracil, or 2-thiouracil, for example.
  • the nucleic acid element preferably is a single-stranded nucleic acid obtained by linking the first nucleic acid portion and the second nucleic acid portion.
  • the secondary structure changes by binding of a detection object to the first nucleic acid portion, and this change is prone to cause a change in secondary structure of the second nucleic acid portion.
  • the first nucleic acid portion and the second nucleic acid portion may be linked via a linker.
  • the nucleic acid preferably is an aptamer, for example.
  • the aptamer generally means a nucleic acid molecule which can specifically bind to a specific target substance.
  • the aptamer may be, for example, DNA or RNA as mentioned above and may be a single-stranded nucleic acid such as a single-stranded RNA or a single-stranded DNA or a double-stranded nucleic acid such as a double-stranded RNA or a double-stranded DNA.
  • the aptamer may be a naturally-derived nucleic acid sequence or a synthesized nucleic acid sequence and may contain peptide nucleic acid such as PNA, the natural nucleic acid (nonartificial nucleic acid), or the artificial nucleic acid.
  • a method for producing an aptamer is not particularly limited, and it can be produced by the above-mentioned conventionally known method, for example.
  • the conventionally known SELEX (Systematic Evolution of Ligands by Exponential Enrichment) method or the like can be employed in the aptamer production, for example.
  • the preparation of an aptamer by the SELEX method is not particularly limited and can be carried out as follows, for example. First, a nucleic acid pool containing a plurality of nucleic acids is provided. Then, the nucleic acid library and a target substance are bound to (associated with) each other to form complexes between them. Thereafter, only a nucleic acid pool involved in formation of the complexes is collected from the complexes. Thus, nucleic acid aptamers which can specifically bind to the secondary reagent can be prepared.
  • a method for preparing nucleic acid aptamers which can specifically bind to a target substance using the SELEX method is shown below as an example. The present invention, however, is not at all limited by this method.
  • the nucleic acid pool is, for example, a library (mixture) of nucleic acids each having a random region.
  • the nucleic acids in the library include polynucleotides such as RNAs and DNAs.
  • the random region is, for example, a region in which bases of A, G, C, and U or bases of A, G, C, and T are randomly linked, and the length thereof is, for example, in the range from 20 to 120 mer.
  • the nucleic acid pool includes preferably from 4 20 to 4 120 types (about from 10 12 to 10 72 types) of nucleic acids, more preferably from 4 30 to 4 60 types (about from 10 18 to 10 36 types) of nucleic acids.
  • each of the polynucleotides contained in the nucleic acid pool has the random region, for example, and the other configuration is not particularly limited. It is preferred that each of the polynucleotides has, for example, in addition to the random region, a primer region utilized in nucleic acid amplification described below, a polymerase recognition region that can be recognized by a polymerase, and the like, at at least one of the 5′-end and 3′-end of the random region.
  • the polymerase recognition region can be decided as appropriate according to the type of polymerase to be used in the nucleic acid amplification described below in preparation of aptamers, for example.
  • the polymerase recognition region is, for example, preferably a DNA-dependent RNA polymerase recognition region (hereinafter, also referred to as an “RNA polymerase recognition region”.), and specifically, a T7 promoter that is a T7 RNA polymerase recognition region.
  • RNA pool can be, for example, an RNA pool containing RNAs each having a structure in which, from the 5′-end side thereof, the RNA polymerase recognition region and the primer region (hereinafter, also referred to as a “5′-end side primer region”.) are linked in this order, the random region is linked to the 3′-end side of the 5′-end side primer region, and the primer region (hereinafter, also referred to as a “3′-end side primer region”.) is linked to the 3′-end side of the random region.
  • RNAs each having a structure in which, from the 5′-end side thereof, the RNA polymerase recognition region and the primer region
  • the primer region hereinafter, also referred to as a “3′-end side primer region”.
  • the 5′-end side primer region in the RNA is, for example, a sequence complementary to the 3′-end of a DNA antisense strand synthesized using the RNA as a template, i.e., a sequence that is the same as a sequence of a primer that can bind to the 3′-end of the antisense strand.
  • the RNA pool may further include a region that assists the binding to a secondary reagent which is a target substance, for example.
  • Each of the polynucleotides in the nucleic acid pool may have a different random region or a random region a part of which is a common sequence. The respective regions in each of the polynucleotides may be directly adjoined to one another or may be indirectly adjoined through intervening sequences.
  • a method for preparing the nucleic acid pool is not particularly limited, and a known method can be employed.
  • the nucleic acid pool can be prepared using an initial pool containing DNAs and, as templates, the DNAs, for example.
  • a DNA strand used as a template of RNAs in a nucleic acid pool is also referred to as an antisense strand
  • a DNA strand having a sequence of any of the RNAs with U replaced by T is also referred to as a sense strand.
  • the initial pool containing DNAs contains, for example, any of DNAs (antisense strands) each obtained by replacing U in a strand complementary to each random region in the RNA pool by T and DNAs (sense strands) each having a sequence obtained by replacing U in each random region by T.
  • Nucleic acid amplification is conducted using each of the DNAs in this initial pool as a template and a DNA-dependent DNA polymerase. Thereafter, a transcription reaction is conducted using each of obtained DNA amplification products as a template and a DNA-dependent RNA polymerase.
  • a nucleic acid pool containing RNAs can be prepared.
  • nucleic acid pool containing RNAs by nucleic acid amplification through a preparation of an initial pool containing DNAs each obtained by replacing U in each random region of each of the RNAs by T and annealing of primers each having an RNA polymerase recognition region and a sequence complementary to a 5′-end side primer region, using the initial pool as a template.
  • a target substance that reacts with the nucleic acid pool may be, for example, the above-described target substance or a degradate thereof
  • a binding form between the nucleic acid pool and the target is not particularly limited and can be, for example, binding via intermolecular force such as a hydrogen bond.
  • a treatment for binding the nucleic acid pool and the target substance can be, for example, a method in which the both are incubated for a certain period of time in a solvent.
  • the solvent is not particularly limited and preferably the one can maintain the binding of the both and the like. Examples of the solvent include various buffer solutions.
  • a reaction solution in which the both are caused to react with each other in order to form a composite contains, besides the composite, a nucleic acid pool (hereinafter referred to as an “unreacted nucleic acid pool”) that does not involved in formation of the composite, for example. Therefore, for example, it is preferred that the composite and the unreacted nucleic acid pool are separated from the reaction solution.
  • a method for separating the composite and the unreacted nucleic acid pool from each other is not particularly limited and can be, for example, a method utilizing the difference in adsorbability between the target substance and the nucleic acid pool or the difference in molecular weight between the composite and the nucleic acid pool.
  • the following method is illustrative, for example. That is, first, a carrier having adsorbability to the target substance and the reaction solution containing the composite are brought into contact with each other. At that time, the unreacted nucleic acid pool is not adsorbed to the carrier. In contrast, the composite of the target substance and the nucleic acid pool is adsorbed to the same. Thus, the unreacted nucleic acid pool and the composite can be separated from each other. Therefore the composite adsorbed to the carrier can be collected after removing the unreacted nucleic acid pool. It is preferred that the carrier is washed in order to completely remove the unreacted nucleic acid pool prior to collection of the composite from the carrier, for example.
  • the carrier having adsorbability to the target substance is not particularly limited and can be selected as appropriate according to the type of the target, for example.
  • the carrier having adsorbability can be, for example, a nitrocellulose film.
  • a method using a carrier can be illustrative, for example.
  • the carrier can be, for example, a carrier having pores each with a pore size with which the nucleic acid pool is allowed to pass therethrough, but the composite is not allowed to pass therethrough.
  • the separation may be, for example, electrical separation using an agarose gel, a polyacrylamide gel, or the like.
  • a method using a target substance immobilized on a carrier in formation of composite can be used, for example. That is, the target substance is previously immobilized on a carrier, and the carrier and the nucleic acid pool are brought into contact with each other. Thus, a composite of the immobilized target substance and the nucleic acid pool is formed. Then, an unreacted nucleic acid pool binding to no immobilized target substance is removed, and thereafter the composite of the target substance and the nucleic acid pool is dissociated from the carrier.
  • a method for immobilizing the target substance on the carrier is not at all limited, and a known method can be employed.
  • the method can be, for example, a method in which the target substance is previously bound to a label, and a carrier having a ligand with the label and the target substance binding to the label are brought into contact with each other.
  • the label can be, for example, a His-tag.
  • the ligand include metal ions such as a nickel ion (Ni 2+ ) and a cobalt ion (Co 2+ ).
  • Specific examples of the carrier include Ni-agarose and Ni-sepharose based on the metal ions.
  • nucleic acid pool involved in formation of the composite is collected from the collected composite.
  • the nucleic acid pool involved in formation of the composite can be collected by releasing a bond between the target substance and the nucleic acid pool, for example.
  • nucleic acid amplification of the collected nucleic acid pool involved in formation of the composite is conducted.
  • a method for amplifying the nucleic acid pool is not particularly limited, and the nucleic acid pool can be amplified by a known method according to the type of the nucleic acid pool, for example.
  • the nucleic acid pool is an RNA pool
  • the RNA pool involved in formation of the composite can be amplified.
  • the nucleic acid amplification can be conducted by an amplification method utilizing these regions, for example.
  • a reverse transcription reaction for preparing the cDNAs using each of the RNAs as a template it is preferred that a polynucleotide having a sequence complementary to the 3′-end side primer region contained in the RNA pool is used as a primer, for example.
  • a polynucleotide having the 5′-end side primer region and a polynucleotide having a strand complementary to the 3′-end side primer region are used as primers, for example.
  • the former polynucleotide further has the RNA polymerase recognition region on the 5′-end side thereof and the 5′-end side primer region on the 3′ side thereof, for example.
  • nucleic acid amplification such as a PCR is conducted using each of the DNA amplification products as a template, a 5′-end side primer region and the 3′-end side primer region in each of the DNAs, and a DNA-dependent DNA polymerase.
  • a polynucleotide containing the 5′-end side primer region and a polynucleotide containing a strand complementary to the 3′-end side primer region are used as primers.
  • the former polynucleotide has the RNA polymerase recognition region on the 5′-end side thereof and the 5′-end side primer region on the 3′ side thereof, for example.
  • a transcription reaction in vitro is conducted using each of obtained amplification products as a template, the RNA polymerase recognition region in each of the amplification products, and the DNA-dependent RNA polymerase.
  • nucleic acid amplification of the RNA pool involved in formation of the composite can be conducted.
  • a DNA of an antisense strand has an RNA polymerase recognition region on the 3′-end side thereof, for example.
  • RNA-dependent RNA polymerase is bound to this region, and each of the RNAs can be synthesized using the antisense strand as a template.
  • the RNA-dependent DNA polymerase used in the reverse transcription reaction is not particularly limited, and a reverse transcriptase derived from avian myeloblastosis virus (AMV Reverse Transcriptase) can be used, for example.
  • the method for amplifying nucleic acid is not particularly limited, and for example, any of a PCR method and various isothermal amplification methods can be employed.
  • the conditions thereof are also not particularly limited.
  • nucleic acid pool forming a composite with a target substance is collected. Further, as mentioned above, formation of composite using a target substance, collection of the composite, separation of a nucleic acid pool involved in formation of the composite, amplification of the separated nucleic acid pool, and the like are repeated. Thus, nucleic acid aptamers having binding properties to the target substance can be eventually obtained.
  • nucleic acid element in the present embodiment examples include the following two forms (1) and (2):
  • the “labeling substance” is an optional component of the nucleic acid element of the present embodiment.
  • the form (1) may be the one in which the secondary structure of the second nucleic acid portion changes by binding of the detection object and the first nucleic acid portion, and by the change in the secondary structure, the labeling substance binding to the second nucleic acid portion is released from the second nucleic acid portion.
  • the form may be the one in which the labeling substance is an enzyme, and an enzyme reaction with the enzyme is inhibited when the enzyme binds to the second nucleic acid portion, and the enzyme reaction is released from being inhibited when the enzyme is released from the second nucleic acid portion.
  • the present embodiment is an example of a detection instrument including a nucleic acid element in the form (1).
  • FIGS. 5A and 5B schematically shows a configuration of the nucleic acid element of the present embodiment.
  • this nucleic acid element 36 includes a first nucleic acid portion (binding portion) 32 and a second nucleic acid portion (labeling portion) 33 , and the first nucleic acid portion 32 and the second nucleic acid portion 33 are integrated by linking to each other.
  • a labeling substance e.g., enzyme
  • the labeling substance 34 is an enzyme
  • the enzyme reaction inhibited by binding the enzyme to the second nucleic acid portion 33 is released from being inhibited by releasing the enzyme from the second nucleic acid portion 33 .
  • an enzyme reaction occurs.
  • the detection object can be detected by detecting this enzyme reaction.
  • the length of each nucleic acid is not particularly limited.
  • the lower limit of the length in each of the first nucleic acid portion and the second nucleic acid portion is not particularly limited and is, for example, 7 bases.
  • the upper limit of the same is not particularly limited and is, for example, 120 bases, preferably 80 bases, more preferably 35 bases, yet more preferably 20 bases, and the shorter the length the more preferable.
  • the range of the length in the first nucleic acid portion is, for example, from 7 to 120 bases, preferably from 7 to 80 bases, more preferably from 7 to 35 bases, yet more preferably from 7 to 20 bases.
  • the upper limit of the length of nucleic acid in the second nucleic acid portion is not particularly limited and is, for example, 120 bases, preferably 80 bases, more preferably 60 bases, yet more preferably 40 bases, particularly preferably 35 bases, and the shorter the length the more preferable.
  • the range of the length in the second nucleic acid portion is, for example, from 7 to 120 bases, preferably from 7 to 80 bases, more preferably from 7 to 60 bases, yet more preferably from 7 to 40 bases, particularly preferably from 7 to 35 bases.
  • the length of nucleic acid in the entire nucleic acid element is not particularly limited, and the range of the length is, for example, from 14 to 240 bases, preferably from 14 to 200 bases, more preferably from 14 to 160 bases, yet more preferably from 14 to 140 bases, particularly preferably from 14 to 75 bases, more particularly preferably from 14 to 55 bases.
  • the length in the first nucleic acid portion may be identical to or different from that in the second nucleic acid portion.
  • the substrate is not particularly limited, and is, for example, preferably a chromogenic substrate that develops a color by an enzyme reaction because it allows detection to be carried out easily.
  • the enzyme include oxidoreductase and phosphatase.
  • the oxidoreductase can be, for example, peroxidase.
  • the phosphatase can be, for example, alkaline phosphatase.
  • examples of the chromogenic substrate includes 3,3′,5,5′-tetramethylbenzidine (TMB), 1,2-phenylenediamine (OPD), 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid ammonium salt (ABTS), 3,3′-diaminobenzidine (DAB), 3,3′-diaminobenzidine tetrahydrochloride hydrate (DAB4HCl), 3-amino-9-ethylcarbazole (AEC), 4-chloro-1-naphthol (4ClN), 2,4,6-tribromo-3-hydroxybenzoic acid, 2,4-dichlorophenol, 4-aminoantipyrine, and 4-aminoantipyrine hydrochloride.
  • TMB 3,3′,5,5′-tetramethylbenzidine
  • OPD 1,2-phenylenediamine
  • ABTS 2,2′-azinobis (3-ethylbenzothiazoline-6-s
  • examples of the chromogenic substrate include 5-bromo-4-chloro-3-indolylphosphate/nitrotetrazolium blue (Nitro-TB), and nitro-blue tetrazolium chloride (NBT).
  • FIGS. 6A and 6B show an example of a nucleic acid element 36 in which aptamers are employed as a first nucleic acid portion 32 and a second nucleic acid portion 33 .
  • the identical parts to those in FIGS. 5A and 5B are denoted by identical reference numerals.
  • the aptamer as the first nucleic acid portion 32 and the aptamer as the second nucleic acid portion 33 bind to each other to form a single-stranded nucleic acid (RNA).
  • RNA single-stranded nucleic acid
  • a labeling substance e.g., enzyme
  • FIG. 6A when a detection object 31 does not bind to the aptamer being the first nucleic acid portion 32 , a labeling substance (e.g., enzyme) 34 binds to the aptamer being the second nucleic acid portion 33 .
  • FIG. 6B when the detection object 31 is present in a sample and binds to the aptamer being the first nucleic acid portion 32 , the structure of the aptamer as the second nucleic acid portion 33 changes, resulting in releasing the labeling substance 34 from the second nucleic acid portion 33 .
  • the labeling substance 34 is an enzyme, and an enzyme reaction inhibited by binding of the enzyme to the second nucleic acid portion 33 is released from being inhibited by releasing the enzyme from the second nucleic acid portion 33 .
  • an enzyme reaction occurs.
  • the detection object 31 can be detected by detecting this enzyme reaction. Note here that FIGS.
  • the other configuration of the nucleic acid element 36 is not particularly limited.
  • the nucleic acid element including aptamers described above can be produced as follows, for example. First, an aptamer as a first nucleic acid portion is obtained using a detection object as a target. An aptamer as a second nucleic acid portion is obtained using a labeling substance (e.g., enzyme) as a target. The above-mentioned SELEX method can be employed as a method for obtaining the aptamers. Then, these two aptamers are caused to bind to each other.
  • a labeling substance e.g., enzyme
  • a method for binding these aptamers is not particularly limited and can be, for example, a method in which a single-stranded nucleic acid sequence is produced from sequences of the two aptamers, and a nucleic acid is synthesized based on this single-stranded nucleic acid sequence.
  • the secondary structures of the two aptamers may be predicted using a computer or the like, and the single-stranded nucleic acid sequence may be revised, or a sequence may be deleted or added to the single-stranded nucleic acid sequence.
  • the present embodiment is an example of a detection instrument including a detection reagent which contains a nucleic acid element in the form (2).
  • the nucleic acid element in the form (2) is characterized in that a second nucleic acid portion itself can cause an enzyme reaction.
  • FIGS. 7A and 7B schematically shows a configuration of the nucleic acid element of the present embodiment.
  • this nucleic acid element 46 includes a first nucleic acid portion (binding portion) 42 and a second nucleic acid portion (labeling portion) 43 , and the first nucleic acid portion 42 and the second nucleic acid portion 43 are integrated by linking to each other.
  • the second nucleic acid portion 43 is associated with the first nucleic acid portion 42 , resulting in the state of inhibiting an enzyme reaction. Then, as shown in FIG. 7B , when the detection object is present in a sample, and the detection object 31 binds to the first nucleic acid portion 42 , the second nucleic acid portion 43 is released from the first nucleic acid portion 42 , and thus, the second nucleic acid portion 43 can cause an enzyme reaction. At that time, when a substrate is present, an enzyme reaction occurs. Thus, the detection object 31 can be detected by detecting this enzyme reaction as in the case of Embodiment 1-1a.
  • the length of nucleic acid is not particularly limited.
  • the length of nucleic acid in each of the first nucleic acid portion and the second nucleic acid portion is, for example, the same as that in Embodiment 1-1a.
  • the length of nucleic acid in the entire nucleic acid element is not particularly limited, and the range of the length is, for example, from 14 to 240 bases, preferably from 14 to 200 bases, more preferably from 14 to 160 bases, yet more preferably from 14 to 140 bases, particularly preferably from 14 to 75 bases, more particularly preferably from 14 to 55 bases.
  • the type of the enzyme reaction of the second nucleic acid portion 43 is not particularly limited and can be, for example, the same enzyme reaction as in Embodiment 1-1a.
  • a nucleic acid which can cause an enzyme reaction can be DNA having Hemin peroxidase activity (Tao et al, Anal. chem. 2009, 81, 2144-2149).
  • the substrate also is not particularly limited and can be, for example, the same substrate as in Embodiment 1-1a.
  • FIGS. 8A to 8D show an example of a nucleic acid element in which an aptamer is employed as a first nucleic acid portion 42 , and DNA having peroxidase activity is employed as a second nucleic acid portion 43 .
  • FIG. 8A shows DNA having peroxidase activity (SEQ ID NO: 1)
  • FIG. 8B shows an aptamer to adenosine (SEQ ID NO: 2).
  • FIG. 8C shows a nucleic acid element of a single-stranded nucleic acid obtained by binding the DNA (A) and the aptamer (B) (SEQ ID NO: 3).
  • SEQ ID NO: 1 shows DNA having peroxidase activity
  • FIG. 8B shows an aptamer to adenosine
  • FIG. 8C shows a nucleic acid element of a single-stranded nucleic acid obtained by binding the DNA (A) and the aptamer (B) (SEQ ID NO: 3).
  • the aptamer (B) does not bind to adenosine, so that the DNA has a secondary structure which cannot cause an enzyme reaction. Then, when the adenosine binds to the aptamer (B) in the nucleic acid element, the secondary structure of the DNA of FIG. 8C changes to the one which can cause an enzyme reaction as shown in FIG. 8D . At that time, when a substrate is present, an enzyme reaction occurs. Thus, the detection object can be detected by detecting this enzyme reaction.
  • This nucleic acid element can be used in measurement of viable cells in food. That is, the presence of viable cells in food means the presence of ATP, and the concentration of ATP is proportional to the number of viable cells. Therefore, when this nucleic acid element, a chromogenic substrate, and food are caused to react, color development in proportion to the concentration of ATP derived from viable cells can be obtained. Thus, the number of viable cells in food can be detected by detecting this color development.
  • This nucleic acid element can be produced as follows, for example. First, an aptamer as a first nucleic acid portion is obtained using a detection object as a target. The above-mentioned SELEX method can be employed as a method for obtaining the aptamer. On the other hand, a sequence of a second nucleic acid portion is designed according to an enzyme reaction and synthesized. Then the aptamer as the first nucleic acid portion and the second nucleic acid portion are caused to bind to each other.
  • a method for binding them is not particularly limited and can be, for example, a method in which a single-stranded nucleic acid sequence is produced from a sequence of the aptamer as the first nucleic acid portion and a sequence of the second nucleic acid portion, and a nucleic acid is synthesized based on this single-stranded nucleic acid sequence.
  • the secondary structures may be predicted using a computer or the like, and the single-stranded nucleic acid sequence may be revised, or a sequence may be deleted or added to the single-stranded nucleic acid sequence.
  • the present embodiment is an example of a detection instrument in which antibodies for capturing a detection object (antigen) are immobilized, as a detection reagent, on the detection portion in the case where the detection object in a sample is a substance which can be an antigen.
  • the antibodies immobilized on the detection portion are not particularly limited as long as they bind to the detection object (antigen) in the sample, and can be any of immunoglobulin (Ig)G, IgA, IgM, IgE, and IgD. These antibodies may be polyclonal antibodies or monoclonal antibodies. These antibodies can be produced by a normal method using an animal such as a mouse, a rat, a goat, or a chicken.
  • FIG. 9 shows an example of immobilizing antibodies on the detection portion.
  • antibodies 61 are immobilized on a detection portion 52 .
  • FIG. 9 schematically shows the example, so that the size and the number of antibodies 61 are different from the actual size and the number.
  • the numeral 11 indicates a main body of a detection instrument as shown in FIGS. 1A and 1B .
  • a sample containing antibodies which have been labeled with an enzyme hereinafter referred to as an “enzyme-labeled antibodies” and a chromogenic substrate corresponding to the enzyme of the enzyme-labeled antibodies are brought into contact with a detection portion 52 .
  • the enzyme-labeled antibodies are not particularly limited as long as they bind to a detection object (antigen) in the sample and may be any of immunoglobulin (Ig)G, IgA, IgM, IgE, and IgD. These antibodies may be polyclonal antibodies or monoclonal antibodies. These antibodies can be produced by a normal method using an animal such as a mouse, a rat, a goat, or a chicken.
  • the enzyme of the enzyme-labeled antibodies and the chromogenic substrate are not particularly limited and can be, for example, the same enzyme and the same chromogenic substrate as in Embodiment 1-1a.
  • the detection object contains the detection object (antigen)
  • the detection object antigen
  • the enzyme-labeled antibodies are bound to each other by an antigen-antibody reaction.
  • FIG. 10 schematically shows an antigen-antibody reaction in the present embodiment.
  • the identical parts to those in FIG. 9 are denoted by identical reference numerals.
  • the detection object (antigen) 71 in a sample binds to antibodies 61 immobilized on the detection portion 52 as well as the enzyme-labeled antibodies 64 , thus forming a complex.
  • the numeral 62 indicates antibodies of the enzyme-labeled antibodies 64
  • the numeral 63 indicates an enzyme of the enzyme-labeled antibodies 64 .
  • FIG. 10 schematically shows the antigen-antibody reaction, the sizes of the antibodies and a label and the like are different from the actual sizes and the like.
  • the detection object can be detected by detecting color development caused by a reaction of the enzyme of the enzyme-labeled antibodies and the chromogenic substrate in the detection portion 52 after predetermined time (not particularly limited and is, for example, from 10 to 20 minutes).
  • a detection object in a sample may be an antibody, and an antigen for capturing the detection object (antibody) may be immobilized, as a detection reagent, on the detection portion.
  • an antigen for capturing the detection object antibody
  • a sample containing antigen which has been labeled with an enzyme hereinafter referred to as an “enzyme-labeled antigen”
  • a chromogenic substrate corresponding to the enzyme of the enzyme-labeled antigen is brought into contact with the detection portion 52 .
  • a positive control which can be read optically is placed in the detection portion of the detection instrument according to the present invention.
  • FIG. 11 shows an example of a configuration of a detection system according to the present invention.
  • this detection system includes the detection instrument according to the present invention shown in FIG. 1A and an optical reader (bar-code reader) 21 .
  • the optical reader (bar-code reader) 21 is connected to a personal computer (PC) 22 .
  • the PC 22 is connectable to a server or a storage medium on a cloud system (hereinafter collectively referred to as a “server”) 23 via a communication network or a cloud system (hereinafter collectively referred to as “communication network”) 24 .
  • Examples of the communication network 24 include the Internet, and LAN (Local Area Network).
  • the PC and the server are optional components, and the detection system according to the present invention is not required to have them.
  • the optical reader is not limited to a bar-code reader as long as it can read color development of the detection reagent in the detection instrument according to the present invention and can be, for example, a camera.
  • a camera integrated in a mobile phone can be used as the optical reader.
  • the method for using the detection system shown in FIG. 11 is as follows, for example. The following method, however, is a mere example, and the present invention is not limited by this.
  • a sample is brought into contact with a detection portion (bar code) 12 .
  • the detection reagent specifically reacts with the detection object and develops a color.
  • the color development of the detection reagent in the detection instrument is read by an optical reader (bar-code reader) 21 .
  • This read result is displayed on the PC 22 . That is, when color development of the detection reagent is read, a read result showing the presence of the detection object in the sample is displayed on the PC 22 . On the other hand, when color development of the detection reagent is not read, a read result showing the absence of the detection object in the sample is displayed on the PC 22 .
  • the read result may be stored in the server 23 via the communication network 24 , and a next detection may be performed with reference to the read result.
  • a next detection may be performed with reference to the read result.
  • production of fermented food can be managed using the detection system of the present embodiment.
  • FIG. 12 shows another example of a configuration of the detection system according to the present invention.
  • this detection system is the same as the detection system of Embodiment 2 shown in FIG. 11 except for including a printer (e.g., an ink jet recording device or a laser printer) 25 connected to a PC 22 .
  • a printer e.g., an ink jet recording device or a laser printer
  • a method for using the detection system shown in FIG. 12 is as follows, for example. The following method, however, is a mere example, and the present invention is not limited by this.
  • a detection portion (bar code) 12 is formed in a main body 11 of a detection instrument with the printer 25 .
  • a specific method for forming the detection portion (bar code) 12 is the same as described in Embodiment 1.
  • the detection portion (bar code) 12 may be formed with reference to the information stored in the server 23 .
  • the kind of the detection reagent may be changed according to the information in order to set microorganisms increased in the season of the detection as the detection object.
  • the detection system of the present embodiment is used in inspection of imported food
  • the kind of the detection reagent may be selected according to the information in order to set the residual pesticide as the detection objects.
  • the detection portion may be formed with reference to information on the Internet or a cloud system as substitute for the information stored in the server 23 , for example.
  • the detection object can be detected in the same manner as in Embodiment 2.
  • the present embodiment is an example of a detection instrument configured so that a detection portion is formed in a main body.
  • FIG. 13A shows a configuration of the detection instrument of the present embodiment.
  • the main body 11 a transparent and colorless plastic container is used.
  • a bar code is formed in the detection portion 12 , and eight detection reagents 1 a to 8 a are placed as parts of the bar code.
  • the detection reagents 1 a to 8 a are placed so as to be adjacent to the respective bars 1 b to 8 b in the detection portion (bar code) 12 . Whether or not the eight kinds of bacteria and virus are present in the sample can be detected by reading whether or not the thicknesses of the bars 1 b to 8 b are increased after the contact.
  • the present embodiment is an example of a detection instrument configured so that a detection reagent contains a nucleic acid element.
  • a nucleic acid element a nucleic acid element containing a first nucleic acid portion and a second nucleic acid portion which is DNA (DNA enzyme) which can cause an enzyme reaction is used.
  • FIG. 13B shows a configuration of the detection instrument of the present embodiment. As shown in FIG. 13B , the detection reagent (nucleic acid elements) containing a chromogenic substrate which develops a color by an enzyme reaction with the second nucleic acid portion is placed at 21 positions of a detection portion 12 .
  • the presence or absence of a detection object which releases the enzyme reaction from being inhibited by binding to the first nucleic acid portion in the sample can be detected from the presence or absence of color development of the detection reagent (nucleic acid element) at 21 positions caused by the contact of the sample with the detection portion 12 .
  • the present embodiment is an example of an immune chromatogram detection instrument configured so that a detection portion is formed in a main body thereof, and antibodies for capturing a detection object (antigens) are immobilized on the detection portion.
  • FIG. 13C shows a configuration of a detection instrument of the present embodiment. As shown in FIG. 13C , a plate for development exerting capillary action is used as a main body 11 . Moreover, a bar code is formed in the detection portion 12 , and as parts of the bar code, four detection reagents 1 a to 4 a are placed in the same. As the four detection reagents 1 a to 4 a , the respective antibodies corresponding to the respective four kinds of bacteria and virus are used.
  • the detection reagents 1 a to 4 a are placed so as to be adjacent to the respective bars 1 b to 4 b in the detection portion (bar code) 12 .
  • a part of the bar code 12 in which the detection reagents 1 a to 4 a are not placed includes information 9 a on the detection reagents such as detection reagent numbers, and information 9 b on a site at which detection is performed.
  • a sample supply portion 81 is formed on one side of the detection portion (bar code) 12 in the main body 11 , and an antibody portion 82 for immobilization is formed on the other side of the same. Antibodies corresponding to any of the four kinds of bacteria and virus are immobilized on the antibody portion 82 for immobilization.
  • a sample containing enzyme-labeled antibodies and a chromogenic substance corresponding to an enzyme of the enzyme-labeled antibodies are brought into contact with the sample supply portion 81 , which is then stood still until color development of the antibody portion 82 for immobilization is detected. Thereafter, whether or not the thicknesses of the bars 1 b to 4 b are increased after the contact with the sample is read by a bar-code reader.
  • the presence or absence of the four kinds of bacteria and virus in the sample can be detected with reference to information on the detection reagents such as detection reagent numbers and information on a site at which detection is performed.
  • the present invention provides a detection instrument and a detection system, by which everyone can easily detect an intended detection object without any skilled technique.
  • the uses of the detection instrument and the detection system are not limited, and they are applicable in various fields such as food, medical cares, agriculture, and environment.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Clinical Laboratory Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plasma & Fusion (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
US13/995,576 2010-12-20 2011-12-19 Detection instrument, and detection system Abandoned US20130273645A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2010283718 2010-12-20
JP2010-283718 2010-12-20
JP2011-229162 2011-10-18
JP2011229162 2011-10-18
PCT/JP2011/079402 WO2012086599A1 (ja) 2010-12-20 2011-12-19 検出用具および検出システム

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2011/079402 A-371-Of-International WO2012086599A1 (ja) 2010-12-20 2011-12-19 検出用具および検出システム

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/143,763 Continuation US10295531B2 (en) 2010-12-20 2016-05-02 Detection instrument, and detection system

Publications (1)

Publication Number Publication Date
US20130273645A1 true US20130273645A1 (en) 2013-10-17

Family

ID=46313869

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/995,576 Abandoned US20130273645A1 (en) 2010-12-20 2011-12-19 Detection instrument, and detection system
US15/143,763 Active 2032-07-25 US10295531B2 (en) 2010-12-20 2016-05-02 Detection instrument, and detection system

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/143,763 Active 2032-07-25 US10295531B2 (en) 2010-12-20 2016-05-02 Detection instrument, and detection system

Country Status (4)

Country Link
US (2) US20130273645A1 (ja)
EP (1) EP2657330A4 (ja)
JP (2) JP6090835B2 (ja)
WO (1) WO2012086599A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180045641A1 (en) * 2016-08-10 2018-02-15 Roche Molecular System, Inc. Plate with wells for chemical or biological reactions, and method for multiple imaging of such a plate by means of an imaging system
CN108414747A (zh) * 2017-02-10 2018-08-17 国家纳米科学中心 条码化层析试纸条的制备方法、其检测装置及应用
CN115078713A (zh) * 2022-05-16 2022-09-20 远大医药（中国）有限公司 一种试剂盒、可信检测结果采集方法及防伪试纸
WO2022218457A1 (de) * 2021-04-14 2022-10-20 Wilfried Ehmer Testvorrichtung und testverfahren für schnell- und selbsttests

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014185905A (ja) * 2013-03-22 2014-10-02 Adc Technology Inc バーコード表示装置
WO2015145851A1 (ja) * 2014-03-26 2015-10-01 Ｎｅｃソリューションイノベータ株式会社 検体検出装置、検体検出システム、検体検出キット、検体検出方法、プログラム、及び記録媒体
TR201716609A2 (ja) * 2017-10-27 2019-05-21 Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296688A (en) * 1989-12-04 1994-03-22 Hamilton David W Apparatus and method for recording progress notes
US20050003458A1 (en) * 2003-06-12 2005-01-06 Mathew Moore Method and system for the analysis of high density cells samples
US20080173718A1 (en) * 2007-01-23 2008-07-24 Nec Infrontia Corporation Barcode reading apparatus and reading method

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157048B2 (en) 1993-05-19 2007-01-02 Sira Technologies, Inc. Detection of contaminants
US20020072079A1 (en) 1993-05-19 2002-06-13 Sira Technologies, Inc. Detection of contaminants in food
US20030113228A1 (en) 1993-05-19 2003-06-19 Goldsmith Robert M. Contamination detection system
DE69733494D1 (de) * 1996-09-30 2005-07-14 California South Pacific Investors Nachweis von Verunreinigungen in Lebensmitteln
US5902982A (en) * 1997-04-04 1999-05-11 National Medical Review Office Inc. Changeable machine readable assaying indicia
US6514461B1 (en) 1997-02-14 2003-02-04 Escreen, Inc. System for automatically testing a fluid specimen
US6770487B2 (en) * 2001-05-01 2004-08-03 Ischemia Technologies, Inc. Bar code readable diagnostic strip test
FR2829854B1 (fr) 2001-09-17 2005-05-13 Renaud Vaillant Procede pour controler un produit dont la conservation met en oeuvre une chaine du froid
DE10220935B3 (de) * 2002-05-10 2004-02-05 Siemens Ag Verfahren für die biochemische Analytik von DNA und zugehörige Anordnung
US20030231986A1 (en) * 2002-06-18 2003-12-18 Eastman Kodak Company Micro-array identification means
AU2003207120A1 (en) 2002-10-24 2004-05-13 Chromic Co., Ltd. Temperature indicating display device
JP2005030825A (ja) * 2003-07-09 2005-02-03 Olympus Corp マイクロアレイの製造装置、製造方法、マイクロアレイ及び生体由来物質の解析方法
DE102004053918B4 (de) * 2004-11-05 2007-06-14 Analyticon Biotechnologies Ag Aptamerbasiertes Testsystem
JP2007046933A (ja) * 2005-08-08 2007-02-22 Tokyo Institute Of Technology 蛍光画像検出方法、蛍光画像検出基板、蛍光画像検出器、プログラムおよび記録媒体
JP2007212391A (ja) * 2006-02-13 2007-08-23 Toppan Forms Co Ltd 検体検査具
US7562811B2 (en) 2007-01-18 2009-07-21 Varcode Ltd. System and method for improved quality management in a product logistic chain
JP2009537038A (ja) 2006-05-07 2009-10-22 バーコード リミティド 製品ロジスティックチェーンにおける品質管理を改善するためのシステムおよび方法
WO2008038696A1 (fr) * 2006-09-27 2008-04-03 National University Corporation Tokyo University Of Agriculture And Technology Procédé de dosage d'une substance cible dans un échantillon, aptamère et son procédé de fabrication
JP5163999B2 (ja) * 2007-11-14 2013-03-13 国立大学法人富山大学 類似植物体および生薬同定用ｄｎａマイクロアレイ
JP5133663B2 (ja) 2007-11-30 2013-01-30 森永製菓株式会社 食品成分抽出方法及び食品検査方法並びに食品検査キット
JP5317221B2 (ja) * 2008-04-01 2013-10-16 日本電気株式会社 アプタマー選抜方法及び装置、ならびにアプタマーを用いたセンサ方法
JP5375173B2 (ja) * 2009-02-23 2013-12-25 株式会社寺岡精工 ラベル発行装置
JP5675053B2 (ja) 2009-03-25 2015-02-25 日油技研工業株式会社 工程管理インジケータ及びそれを用いた工程管理方法
JP5419138B2 (ja) * 2009-03-27 2014-02-19 Ｎｅｃソフト株式会社 検出対象物の検出方法およびそれに用いる検出用キット
JP2010282325A (ja) * 2009-06-03 2010-12-16 Denso Wave Inc 光学的情報読取装置
JP5881154B2 (ja) * 2009-08-07 2016-03-09 Ｎｅｃソリューションイノベータ株式会社 分析用核酸素子、それを用いた分析方法、分析用試薬および分析用具

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296688A (en) * 1989-12-04 1994-03-22 Hamilton David W Apparatus and method for recording progress notes
US20050003458A1 (en) * 2003-06-12 2005-01-06 Mathew Moore Method and system for the analysis of high density cells samples
US20080173718A1 (en) * 2007-01-23 2008-07-24 Nec Infrontia Corporation Barcode reading apparatus and reading method

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180045641A1 (en) * 2016-08-10 2018-02-15 Roche Molecular System, Inc. Plate with wells for chemical or biological reactions, and method for multiple imaging of such a plate by means of an imaging system
US11385170B2 (en) * 2016-08-10 2022-07-12 Roche Molecular Systems, Inc. Plate with wells for chemical or biological reactions, and method for multiple imaging of such a plate by means of an imaging system
CN108414747A (zh) * 2017-02-10 2018-08-17 国家纳米科学中心 条码化层析试纸条的制备方法、其检测装置及应用
WO2022218457A1 (de) * 2021-04-14 2022-10-20 Wilfried Ehmer Testvorrichtung und testverfahren für schnell- und selbsttests
CN115078713A (zh) * 2022-05-16 2022-09-20 远大医药（中国）有限公司 一种试剂盒、可信检测结果采集方法及防伪试纸

Also Published As

Publication number Publication date
US20160245798A1 (en) 2016-08-25
EP2657330A1 (en) 2013-10-30
WO2012086599A1 (ja) 2012-06-28
EP2657330A4 (en) 2015-01-14
JP6090835B2 (ja) 2017-03-08
JPWO2012086599A1 (ja) 2014-05-22
JP2016033514A (ja) 2016-03-10
US10295531B2 (en) 2019-05-21

Similar Documents

Publication Publication Date Title
US10295531B2 (en) Detection instrument, and detection system
Yang et al. Rapid veterinary diagnosis of bovine reproductive infectious diseases from semen using paper-origami DNA microfluidics
Srisa-Art et al. Highly sensitive detection of Salmonella typhimurium using a colorimetric paper-based analytical device coupled with immunomagnetic separation
US9689025B2 (en) Nucleic acid element for use in analysis, and analytical method, analytical reagent, and analytical instrument using same
Bhunia One day to one hour: how quickly can foodborne pathogens be detected?
Magnaghi et al. Colorimetric sensor array for monitoring, modelling and comparing spoilage processes of different meat and fish foods
Sun et al. A HCR based multivalent aptamer amplifier for ultrasensitive detection of Salmonella
Kumar et al. Rapid point‐of‐care testing methods/devices for meat species identification: A review
Pereira et al. From the field to the bottle—an integrated strategy for wine authenticity
US20230021971A1 (en) Biologic Machines for the Detection of Biomolecules
Oh et al. Rapid and simple detection of ochratoxin a using fluorescence resonance energy transfer on lateral flow immunoassay (FRET-LFI)
Shanker et al. Nanotechnology and detection of microbial pathogens
Li et al. A label-free and sensitive fluorescent qualitative assay for bisphenol a based on rolling circle amplification/exonuclease III-combined cascade amplification
Xie et al. Selection and application of ssDNA aptamers for fluorescence biosensing detection of malachite green
Calabria et al. Luminescent aptamer-based bioassays for sensitive detection of food allergens
Yu et al. A sensitive aptamer fluorescence anisotropy sensor for Cd2+ using affinity-enhanced aptamers with phosphorothioate modification
Xu et al. Visual detection of chicken adulteration based on a lateral flow strip-PCR strategy
Flores-Contreras et al. Detection of emerging pollutants using aptamer-based biosensors: recent advances, challenges, and outlook
Rutten et al. Highly Sensitive Multiplex Detection of Molecular Biomarkers Using Hybridization Chain Reaction in an Encoded Particle Microfluidic Platform
US20140106974A1 (en) Pathogen identification process and transport container
Carrara et al. A Molecular Toolbox to Identify and Quantify Grape Varieties: On the Trace of “Glera”
Bokhari Exploitation of microbial forensics and nanotechnology for the monitoring of emerging pathogens
Lin et al. Self-assembly of functional nucleic acid-based colorimetric competition assay for the detection of immunoglobulin E
Nguyen et al. A rotatable paper device integrating reverse transcription loop-mediated isothermal amplification and a food dye for colorimetric detection of infectious pathogens
Bansal et al. Environmental impact of sensing devices

Legal Events

Date Code Title Description
AS Assignment

Owner name: NEC CORPORATION, JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WAGA, IWAO;REEL/FRAME:030653/0756

Effective date: 20130528

AS Assignment

Owner name: NEC SOFT, LTD., JAPAN

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 030653 FRAME 0786. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE AS: NEC SOFT, LTD., 18-7, SHINKIBA 1-CHOME, KOTO-KU, TOKYO, JAPAN;ASSIGNOR:WAGA, IWAO;REEL/FRAME:030763/0650

Effective date: 20130528

AS Assignment

Owner name: NEC SOLUTION INNOVATORS, LTD., JAPAN

Free format text: CHANGE OF NAME;ASSIGNOR:NEC SOFT, LTD.;REEL/FRAME:033290/0523

Effective date: 20140401

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION